Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and blood lipid-lowering technology, applied in the new field of medicine
Inactive Publication Date: 2010-07-07
BEIJING HOPE HUGE PHARM SCI
View PDF0 Cites 11 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The average plasma half-life of atorvastatin is about 14 hours, but due to the influence of
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0038] Pass probucol, atorvastatin, xylitol, mannitol and other raw and auxiliary materials through a 50-mesh sieve respectively, mix them uniformly by using an equal-volume increasing method, add 3% PVPk-30 ethanol solution, and make a soft material with a 24-mesh sieve Granules, dried, granulated with a 20-mesh sieve, dried, added other flavoring agents, sweeteners, and glidants, mixed evenly, compressed into tablets, and obtained.
[0043] Pass probucol, atorvastatin and other raw materials through 80-mesh sieve, mix well, add 75% ethanol solution, make soft material, granulate with 16-mesh sieve, dry, granulate with 20-mesh sieve, add other flavoring agents Sweet orange essence, sweetener aspartame, and disintegrant PPVP are mixed evenly, and pressed into tablets to obtain the product.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses an officinal composition for lowering blood fat. Active ingredients are atorvastatin and probucol. The invention provides a better fat regulating drug for patients clinically suffering from severe lipid metabolism disorders and especially has favorable synergistic effect on patients at high liver function damaging risk level by drug combination; two kinds of drugs complement advantages so as to obviously lower the possibility of side effect occurrence because of increased amount of atorvastatin. The officinal composition for lowering blood fat is prepared from active ingredients and pharmaceutically acceptable supplementary materials, but is not limited in preparations, such as tablets, dispersible tablets, sustained release tablets and the like.
Description
technical field [0001] The invention belongs to the field of new medicine technology and relates to a blood lipid-lowering medicinal composition. Background technique [0002] Hypertension and hyperlipidemia have become a common disease and frequently-occurring disease. [0003] Atorvastatin is a statin blood lipid regulating drug and is an HMG-CoA reductase inhibitor. It itself is inactive, and the hydrolyzate after oral absorption competitively inhibits the rate-limiting enzyme hydroxymethylglutaryl-CoA reductase in the process of cholesterol synthesis in vivo, reducing the synthesis of cholesterol and increasing the synthesis of low-density lipoprotein receptors , the main site of action is in the liver. As a result, blood cholesterol and low-density lipoprotein cholesterol levels are reduced, serum triglyceride levels are moderately reduced, and blood high-density lipoprotein levels are increased. Thus, it has an effect on the prevention and treatment of atherosclerosi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.